Why COVID-19 Mass Vaccination is a Military Operation
In an exclusive interview with Alexandria (Sasha) Latypova, MBA, who is a former pharmaceutical executive and independent analyst. She has made it clear with her prior reports on TrialSite News that deaths reported in VAERS after COVID-19 vaccination are not randomly distributed according to manufacturing lots as they are with influenza vaccines; instead, they are aggregated in specific “hot lots.”
For example, from data on 33 lots of the Pfizer vaccine, 80% of the deaths have arisen from 35% of the lots.For Moderna, its only 24% of the lots account for 80% of the deaths.Lot sizes were small initially, and some were contaminated by the metallic beads used in the manufacturing process.This explains reports and videos of injection site magnetism early in the campaign and why over time, these claims dissipated.
The lot sizes became larger, and the rushed nature of vaccine manufacturing invariable loads specific lots with more viable intact mRNA, while others have considerably less genetic material and or broken fragments of mRNA.Because the US Department of Defense, under the Emergency Use Authorization countermeasures program, is the ”developer” of the vaccines, there is a complex array of biological defense contractors that make the components of the vaccines.
Specifically, private contractors do the fill-and-finish manufacturing, and the DOD or its designees has material possession of the products until delivery at a vaccine center. So what are the roles of Pfizer and Moderna?
At this stage, they are essentially marketing shields or the corporate “face” of the military program. But Ms. Latypova is clear, by the US EUA regulations, COVID-19 mass vaccination is a DOD operation, and the signal to “go” is given by the US Secretary of Health and Human Services (HHS). Under Trump, it was Alex Azar, and now with Biden, it’s Xavier Becerra.
Essentially if the HHS Secretary believes a national medical emergency exists, then DARPA, the branch of the military dealing with biological threats, is activated, and the process starts. Here is a quote from the DARPA website:
“As part of the Autonomous Diagnostics to Enable Prevention and Therapeutics (ADEPT) program in 2011, DARPA began investing in nucleic acid vaccines. The hypothesis was that rather than delivering antigens to the immune system, we could deliver genes that encode the antigen and allow the human body to produce the antigen from its own cells, triggering a protective immune response. In December 2020, former ADEPT performer Moderna’s RNA vaccine received FDA Emergency Use Authorization (EUA) approval for the prevention of COVID-19.”1
So, it is fully disclosed that the genetic vaccines were not a product of Operation Warp Speed and developed in just a few months; rather, DARPA has been working on them with companies such as Moderna since 2011. What is the role of the FDA?2 Latypova points out it is largely “theatre.” In other words, the FDA is giving sham approvals to versions of the vaccines as they move forward since they are powerless to stop it.